medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2017, Number 03-04

<< Back Next >>

Medicina & Laboratorio 2017; 23 (03-04)

Alopecia areata and Helicobacter pylori: a new association

Campuzano-Maya G

Language: Spanish
References: 173
Page: 149-158
PDF size: 566.20 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Rosenstein ED, Warshauer BL. Alopecia areata and autoimmunity. J Am Acad Dermatol 2010;62:1065.

  2. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev 2015;14:81-89.

  3. Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians. Int J Dermatol 2002;41:748-753.

  4. Treem WR, Veligati LN, Rotter JI, Targan SR, Hyams JS. Ulcerative colitis and total alopecia in a mother and her son. Gastroenterology 1993;104:1187-1191.

  5. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20:1055-1060.

  6. Campuzano-Maya G. Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol 2011;17:3165-3170.

  7. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG, British Association of D. Guidelines for the management of alopecia areata. Br J Dermatol 2003;149:692-699.

  8. Campuzano-Maya G. An optimized 13C-urea breath test for the diagnosis of H pylori infection. World J Gastroenterol 2007;13:5454-5464.

  9. Campuzano-Maya G. Prueba de aliento optimizada con urea marcada con carbono 13 para la detección de Helicobacter pylori (PAU-13C Hp®). Medicina & Laboratorio 2012;18:137-160.

  10. Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helico- bacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781.

  11. Behrangi E, Mansouri P, Agah S, Ebrahimi Daryani N, Mokhtare M, Azizi Z, et al. Association between Helicobacter Pylori infec- tion and alopecia areata: A study in iranian population. Middle East Journal of Digestive Diseases 2017;9:107-110.

  12. Mitchell HM, Kaakoush NO, Sutton P. Extragastric manifestations of Helicobacter pylori infection In: Helicobacter pylori in the twenty-first century, edited by Sutton P, Mitchell HM. UK: CPI Antony Rowe, Chipenham, 2010, p. 69-93.

  13. Pacifico L, Osborn JF, Tromba V, Romaggioli S, Bascetta S, Chiesa C. Helicobacter pylori infection and extragastric disorders in children: a critical update. World J Gastroenterol 2014;20:1379-1401.

  14. Kyburz A, Muller A. Helicobacter pylori and extragastric diseases. Curr Top Microbiol Immunol 2017;400:325-347.

  15. Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol 2014;20:12818-12838.

  16. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection- -the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-664.

  17. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infectionthe Maastricht V/Florence Consensus Report. Gut 2017;66:6-30.

  18. Hernando-Harder AC, Booken N, Goerdt S, Singer MV, Harder H. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009.

  19. Galadari IH, Sheriff MO. The role of Helicobacter pylori in urticaria and atopic dermatitis. Skinmed 2006;5:172-176.

  20. Abdou AG, Elshayeb EI, Farag AG, Elnaidany NF. Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies. Int J Dermatol 2009;48:464-469.

  21. Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol 2010;10:362-369.

  22. Bruscky DM, da Rocha LA, Costa AJ. Recurrence of chronic urticaria caused by reinfection by Helicobacter pylori. Rev Paul Pediatr 2013;31:272-275.

  23. Rasooly MM, Moye NA, Kirshenbaum AS. Helicobacter pylori: A significant and treatable cause of chronic urticaria and angioedema. Nurse Pract 2015;40:1-6.

  24. Mogaddam MR, Yazdanbod A, Ardabili NS, Maleki N, Isazadeh S. Relationship between Helicobacter pylori and idiopathic chronic urticaria: effectiveness of Helicobacter pylori eradication. Postepy Dermatol Alergol 2015;32:15-20.

  25. Gu H, Li L, Gu M, Zhang G. Association between Helicobacter pylori infection and chronic urticaria: A meta-analysis. Gastroen- terol Res Pract 2015;2015:486974.

  26. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol 1994;89:1603-1604.

  27. Mini R, Figura N, D’Ambrosio C, Braconi D, Bernardini G, Di Simplicio F, et al. Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics 2005;5:777-787.

  28. Szlachcic A, Sliwowski Z, Karczewska E, Bielanski W, Pytko-Polonczyk J, Konturek SJ. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol 1999;50:777-786.

  29. Mayr-Kanhäuser S, Kranke B, Kaddu S, Mullegger RR. Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. Eur J Gastroenterol Hepatol 2001;13:1379-1383.

  30. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002;16:328-333.

  31. Díaz C, O’Callaghan CJ, Khan A, Ilchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003;83:282-286.

  32. Argenziano G, Donnarumma G, Iovene MR, Arnese P, Baldassarre MA, Baroni A. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol 2003;42:601-604.

  33. Zandi S, Shamsadini S, Zahedi MJ, Hyatbaksh M. Helicobacter pylori and rosacea. East Mediterr Health J 2003;9:167-171.

  34. Boixeda de Miquel D, Vazquez Romero M, Vazquez Sequeiros E, Foruny Olcina JR, Boixeda de Miquel P, Lopez San Roman A, et al. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev Esp Enferm Dig 2006;98:501-509.

  35. Dakovic Z, Vesic S, Vukovic J, Milenkovic S, Jankovic-Terzic K, Dukic S, et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series. Acta Dermatovenerol Alp Panonica Adriat 2007;16:83-86.

  36. Ali M, Whitehead M. Clearance of chronic psoriasis after eradication therapy for Helicobacter pylori infection. J Eur Acad Derma- tol Venereol 2008;22:753-754.

  37. Martin Hübner A, Tenbaum SP. Complete remission of palmoplantar psoriasis through Helicobacter pylori eradication: a case report. Clin Exp Dermatol 2008;33:339-340.

  38. Bhattarai S, Agrawal A, Rijal A, Majhi S, Pradhan B, Dhakal SS. The study of prevalence of Helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J (KUMJ) 2012;10:49-52.

  39. El-Khalawany M, Mahmoud A, Mosbeh AS, F ABDA, Ghonaim N, Abou-Bakr A. Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients. J Dermatol 2012;39:989-995.

  40. Gravina A, Federico A, Ruocco E, Lo Schiavo A, Masarone M, Tuccillo C, et al. Helicobacter pylori infection but not small intesti- nal bacterial overgrowth may play a pathogenic role in rosacea. United European Gastroenterol J 2015;3:17-24.

  41. Jorgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2017.

  42. Campuzano-Maya G, Ruiz-Restrepo MC. Psoriasis of Helicobacter pylori infection. en proceso 2017.

  43. Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F, et al. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995;33:876-879.

  44. Machet L, Vaillant L, Machet MC, Buchler M, Lorette G. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology 1997;194:86.

  45. Mozrzymas R, d’Amore ES, Montini G, Guariso G. Schönlein-Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: a case report. Pediatr Med Chir 1997;19:467-468.

  46. Cecchi R, Torelli E. Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. J Dermatol 1998;25:482-484.

  47. Fu KI, Yagi S, Mashimo Y, Sugitani K, Imamaki K, Yanagisawa M, et al. Regression of Helicobacter pylori-negative duodenal ulcers complicated by Schönlein-Henoch purpura with H. pylori eradication therapy: the first report. Dig Dis Sci 2005;50:381-384.

  48. Grivceva-Panovska V, Grivceva Stardelova K, Serafimoski V. Henoch-Schönlein purpura in an adult patient: extragastric, cutane- ous manifestation of Helicobacter pylori infection. Prilozi 2008;29:291-301.

  49. Hoshino C. Adult onset Schönlein-Henoch purpura associated with Helicobacter pylori infection. Intern Med 2009;48:847-851.

  50. Avci O, Ellidokuz E, Simsek I, Buyukgebiz B, Gunes AT. Helicobacter pylori and Behcet’s disease. Dermatology 1999;199:140-143.

  51. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet’s disease. Clin Exp Immunol 2005;139:371-378.

  52. Neri S, Ierna D, D’Amico RA, Giarratano G, Leotta C. Helicobacter pylori and prurigo nodularis. Hepatogastroenterology 1999;46:2269-2272.

  53. Kandyil R, Satya NS, Swerlick RA. Chronic pruritus associated with Helicobacter pylori. J Cutan Med Surg 2002;6:103-108.

  54. Reinauer S, Goerz G, Ruzicka T, Susanto F, Humfeld S, Reinauer H. Helicobacter pylori in patients with systemic sclerosis: detec- tion with the 13C-urea breath test and eradication. Acta Derm Venereol 1994;74:361-363.

  55. Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 1998;25:650-653.

  56. Danese S, Zoli A, Cremonini F, Gasbarrini A. High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol 2000;27:1568-1569.

  57. Farina G, Rosato E, Francia C, Proietti M, Donato G, Ammendolea C, et al. High incidence of Helicobacter pylori infection in patients with systemic sclerosis: association with Sicca Syndrome. Int J Immunopathol Pharmacol 2001;14:81-85.

  58. Aragona P, Magazzu G, Macchia G, Bartolone S, Di Pasquale G, Vitali C, et al. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren’s syndrome. J Rheumatol 1999;26:1306-1311.

  59. Sorrentino D, Faller G, DeVita S, Avellini C, Labombarda A, Ferraccioli G, et al. Helicobacter pylori associated antigastric autoantibodies: role in Sjögren’s syndrome gastritis. Helicobacter 2004;9:46-53.

  60. De Vita S, Ferraccioli G, Avellini C, Sorrentino D, Dolcetti R, Di Loreto C, et al. Widespread clonal B-cell disorder in Sjögren’s syndrome predisposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology 1996;110:1969-1974.

  61. Nishimura M, Miyajima S, Okada N. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren’s Syndrome. J Dermatol 2000;27:450-452.

  62. Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadstrom T. Seroprevalence of Helicobacter pylori in primary Sjögren’s syndrome. Clin Exp Rheumatol 2001;19:633-638.

  63. Kürkçüoğlu N, Aksoy F. Sweet’s syndrome associated with Helicobacter pylori infection. J Am Acad Dermatol 1997;37:123-124.

  64. Di Campli C, Gasbarrini A, Nucera E, Franceschi F, Ojetti V, Sanz Torre E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998;43:1226-1229.

  65. Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002;3:273-282.

  66. Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969;81:877- 881.

  67. Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A. Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 2005;5:11.

  68. Ishak RS, Piliang MP. Association between alopecia areata, psoriasis vulgaris, thyroid disease, and metabolic syndrome. J Investig Dermatol Symp Proc 2013;16:S56-57.

  69. Diaz-Angulo S, Lopez-Hoyos M, Munoz-Cacho P, Lopez-Escobar M, Gonzalez-Lopez MA. High prevalence of thyroid autoimmunity in patients with alopecia areata and vitiligo: a controlled study. Australas J Dermatol 2015;56:142-143.

  70. Noso S, Park C, Babaya N, Hiromine Y, Harada T, Ito H, et al. Organ specificity in autoimmune diseases: thyroid and islet autoimmunity in alopecia areata. J Clin Endocrinol Metab 2015;100:1976-1983.

  71. Saylam Kurtipek G, Cihan FG, Erayman Demirbas S, Ataseven A. The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int 2015;2015:435947.

  72. Bin Saif GA. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J 2016;37:656-661.

  73. Kumar P, Gupta A. Dermatoglyphic patterns in psoriasis, vitiligo and alopecia areata. Indian J Dermatol Venereol Leprol 2010;76:185-186.

  74. Ghajarzadeh M, Ghiasi M, Kheirkhah S. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran 2012;50:511-515.

  75. Harris JE. Vitiligo and alopecia areata: apples and oranges? Exp Dermatol 2013;22:785-789.

  76. Krishnaram AS, Saigal A, Adityan B. Alopecia areata - vitiligo overlap syndrome: an emerging clinical variant. Indian J Dermatol Venereol Leprol 2013;79:535-537.

  77. Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr 2016;28:463-469.

  78. Drucker AM, Thompson JM, Li WQ, Cho E, Li T, Guttman-Yassky E, et al. Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses’ Health Study 2. Allergy 2017;72:831-834.

  79. Takahashi N, Sugaya M, Oka T, Miyagaki T, Sato S. Alopecia areata, thyroiditis and vitiligo vulgaris in a Japanese patient with smoldering type adult T-cell leukemia/lymphoma. J Dermatol 2017;44:e79-e80.

  80. Mohan GC, Silverberg JI. Association of vitiligo and alopecia areata with atopic dermatitis: A systematic review and meta-analysis. JAMA Dermatol 2015;151:522-528.

  81. Ronchese F. Psoriasis and alopecia areata in the same patient. R I Med J 1974;57:68-69.

  82. Ganor S. Diseases sometimes associated with psoriasis. II. Alopecia areata. Dermatologica 1977;154:338-341.

  83. Rosina P, Segalla G, Magnanini M, Chieregato C, Barba A. Turner’s syndrome associated with psoriasis and alopecia areata. J Eur Acad Dermatol Venereol 2003;17:50-52.

  84. Criado PR, Valente NY, Michalany NS, Martins JE, Romiti R, Aoki V, et al. An unusual association between scalp psoriasis and ophiasic alopecia areata: the Renbok phenomenon. Clin Exp Dermatol 2007;32:320-321.

  85. Yang YC, Cheng YW, Lai CS, Chen W. Prevalence of childhood acne, ephelides, warts, atopic dermatitis, psoriasis, alopecia areata and keloid in Kaohsiung County, Taiwan: a community-based clinical survey. J Eur Acad Dermatol Venereol 2007;21:643-649.

  86. Catanzaro D, Andrien M, Labbe M, Toungouz-Nevessignsky M. Computer-aided human leukocyte antigen association studies: a case study for psoriasis and severe alopecia areata. Hum Immunol 2010;71:783-788.

  87. Ito T, Hashizume H, Takigawa M. Contact immunotherapy-induced Renbok phenomenon in a patient with alopecia areata and psoriasis vulgaris. Eur J Dermatol 2010;20:126-127.

  88. Slowinska M, Kardynal A, Warszawik O, Czuwara J, Rudnicka L. Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy. J Dermatol Case Rep 2010;4:15-17.

  89. Murao K, Hida Y, Minato M, Kubo Y, Arase S. Relapsing polychondritis associated with psoriasis vulgaris and alopecia areata. Eur J Dermatol 2011;21:779-780.

  90. Poot F, Antoine E, Gravellier M, Hirtt J, Alfani S, Forchetti G, et al. A case-control study on family dysfunction in patients with alopecia areata, psoriasis and atopic dermatitis. Acta Derm Venereol 2011;91:415-421.

  91. Wylie GR, Burden D. Renbok phenomenon between psoriasis and alopecia areata. Clin Exp Dermatol 2011;36:816-817.

  92. Khaled A, Hawilo A, Zaouak A, Zeglaoui F, Kharfi M, Kamoun MR. Association between scalp psoriasis and alopecia areata. Tunis Med 2012;90:344.

  93. Navarro R, Dauden E, Gallo E, Santiago Sanchez-Mateos D, Garcia-Diez A. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature. Skin Pharmacol Physiol 2012;25:107-110.

  94. Ono S, Miyachi Y, Arakawa A. Hair regrowth following TNF-alpha blockade in coexisting psoriasis vulgaris and alopecia areata. Eur J Dermatol 2013;23:537.

  95. Ovcharenko Y, Serbina I, Zlotogorski A, Ramot Y. Renbok phenomenon in an alopecia areata patient with psoriasis. Int J Tricho- logy 2013;5:194-195.

  96. Dogruk Kacar S, Ozuguz P, Polat S. Coexistence of psoriasis, and alopecia areata with trachyonychia in a pediatric patient with Turner Syndrome. Arch Argent Pediatr 2014;112:e209-212.

  97. Karia SB, De Sousa A, Shah N, Sonavane S, Bharati A. Psychiatric morbidity and quality of life in skin diseases: A comparison of alopecia areata and psoriasis. Ind Psychiatry J 2015;24:125-128.

  98. Mrowietz U, Gerdes S, Glaser R, Schroder O. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthri- tis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman. Acta Derm Venereol 2017;97:283-284.

  99. Schepis C, Siragusa M, Happle R. Psoriasis and alopecia areata in a Down syndrome patient: a Renbok phenomenon. Eur J Der- matol 2017;27:300-301.

  100. Sato M, Saga K, Takahashi H. Postmenopausal frontal fibrosing alopecia in a Japanese woman with Sjögren’s syndrome. J Der- matol 2008;35:729-731.

  101. Levin RM, Travis SF, Heymann WR. Simultaneous onset of alopecia areata and idiopathic thrombocytopenic purpura: A potential association? Pediatr Dermatol 1999;16:31-34.

  102. Cohn SM, Buchanan GR. Immune thrombocytopenia and alopecia areata: spontaneous occurrence and resolution in the same patient. Pediatr Blood Cancer 2014;61:2110-2111.

  103. Salman A, Eser A. Concurrence of immune thrombocytopenic purpura and alopecia areata: A rare association. Int J Trichology 2016;8:52-53.

  104. De Luis DA, Varela C, de La Calle H, Canton R, de Argila CM, San Roman AL, et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998;26:259-263.

  105. Figura N, Di Cairano G, Loré F, Guarino E, Gragnoli A, Cataldo D, et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999;50:817-826.

  106. Triantafillidis JK, Georgakopoulos D, Gikas A, Merikas E, Peros G, Sofroniadou K, et al. Relation between Helicobacter pylori infection, thyroid hormone levels and cardiovascular risk factors on blood donors. Hepatogastroenterology 2003;50 Suppl 2:cccxviii-cccxx.

  107. Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B, et al. Decrease in thyroid autoantibodies after erad- ication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004;61:650-652.

  108. Franceschi F, Satta MA, Mentella MC, Penland R, Candelli M, Grillo RL, et al. Helicobacter pylori infection in patients with Hashimoto’s thyroiditis. Helicobacter 2004;9:369.

  109. Sterzl I, Hrda P, Potuznikova B, Matucha P, Hana V, Zamrazil V. Autoimmune thyroiditis and Helicobacter pylori--is there a con- nection? Neuro Endocrinol Lett 2006;27 Suppl 1:41-45.

  110. Sterzl I, Hrda P, Matucha P, Cerovska J, Zamrazil V. Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008;57 Suppl 1:S135-141.

  111. Bassi V, Marino G, Iengo A, Fattoruso O, Santinelli C. Autoimmune thyroid diseases and Helicobacter pylori: The correlation is present only in Graves’s disease. World J Gastroenterol 2012;18:1093-1097.

  112. Fiorini G, Zullo A, Castelli V, Lo Re G, Holton J, Vaira D. Role of Helicobacter pylori infection in the thyroid diseases. J Gastrointestin Liver Dis 2013;22:261-263.

  113. Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: A meta-analysis. Thyroid 2013;23:1294-1300.

  114. Choi YM, Kim TY, Kim EY, Jang EK, Jeon MJ, Kim WG, et al. Association between thyroid autoimmunity and Helicobacter pylori infection. Korean J Intern Med 2017;32:309-313.

  115. Dogan Z, Ozdemir P, Eksioglu M, Filik L. Relationship between Helicobacter pylori infection and vitiligo: A prospective study. Am J Clin Dermatol 2014.

  116. Howitz J, Schwartz M. Vitiligo, achlorhydria, and pernicious anaemia. Lancet 1971;1:1331-1334.

  117. Fairfax AJ, Leatham A. Idiopathic heart block: association with vitiligo, thyroid disease, pernicious anaemia, and diabetes melli- tus. Br Med J 1975;4:322-324.

  118. Gulden KD. Pernicious anemia, vitiligo, and infertility. J Am Board Fam Pract 1990;3:217-220.

  119. Held JL, Kohn SR. Vitiligo and pernicious anemia presenting as congestive heart failure. Cutis 1990;46:268-270.

  120. Abraham Z, Rozenbaum M, Gluck Z, Feuerman EJ, Lahat N, Kinarty A. Vitiligo, rheumatoid arthritis and pernicious anemia. J Dermatol 1993;20:418-423.

  121. Egli F, Walter R. Images in clinical medicine. Vitiligo and pernicious anemia. N Engl J Med 2004;350:2698.

  122. Suzuki C, Hirai Y, Terui K, Kohsaka A, Akagi T, Suda T. Slowly progressive type 1 diabetes mellitus associated with vitiligo vulgaris, chronic thyroiditis, and pernicious anemia. Intern Med 2004;43:1183-1185.

  123. Montes LF, Diaz ML, Lajous J, Garcia NJ. Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis 1992;50:39-42.

  124. Karadag AS, Tutal E, Ertugrul DT, Akin KO, Bilgili SG. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo. Clin Exp Dermatol 2012;37:62-64.

  125. Mesquita PM, Diogo AF, Jorge MT, Berbert AL, Mantese SA, Rodrigues JJ. Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis. An Bras Dermatol 2017;92:52-57.

  126. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004;124:91- 96.

  127. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, et al. Immune Response to CagA protein is associated with im- proved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007;12:36-42.

  128. Campuzano-Maya G. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America. Helicobacter 2007;12:265-273.

  129. Stasi R, Provan D. Helicobacter pylori and Chronic ITP. Hematology Am Soc Hematol Educ Program 2008;2008:206-211.

  130. Bai Y, Wang Z, Bai X, Yu Z, Cao L, Zhang W, et al. Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura. Int J Hematol 2009;89:142-149.

  131. Banic M, Franceschi F, Babic Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2012;17 Suppl 1:49-55.

  132. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.

  133. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001;97:812-814.

  134. Emilia G, Luppi M, Morselli M, Potenza L, D’Apollo N, Torelli G. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Br J Haematol 2002;118:1198-1199.

  135. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002;118:584-588.

  136. Veneri D, Franchini M, Gottardi M, D’Adda M, Ambrosetti A, Krampera M, et al. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002;87:1177-1179.

  137. Hashino S, Mori A, Suzuki S, Izumiyama K, Kahata K, Yonezumi M, et al. Platelet recovery in patients with idiopathic thrombo- cytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 2003;77:188-191.

  138. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003;82:30-32.

  139. Ando T, Tsuzuki T, Mizuno T, Minami M, Ina K, Kusugami K, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004;9:443-452.

  140. Nomura S, Inami N, Kanazawa S. The effects of Helicobacter pylori eradication on chemokine production in patients with im- mune thrombocytopenic purpura. Eur J Haematol 2004;72:304-305.

  141. Sato K, Nagai T, Muroi K, Komatsu N, Ozawa K. [Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura--the associateion between the activity of Helicobacter pylori and platelet recovery]. Rinsho Ketsueki 2004;45:1252- 1254.

  142. Fujimura K. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Int J Hematol 2005;81:113-118.

  143. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005;35:214-219.

  144. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005;118:414-419.

  145. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 2005;100:1265-1270.

  146. Tsutsumi Y, Kanamori H, Yamato H, Ehira N, Kawamura T, Umehara S, et al. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Ann Hematol 2005;84:807-811.

  147. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets 2005;16:117-119.

  148. Asahi A, Kuwana M, Suzuki H, Hibi T, Kawakami Y, Ikeda Y. Effects of a Helicobacter pylori eradication regimen on anti-pla- telet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica 2006;91:1436-1437.

  149. Sayan O, Akyol Erikci A, Ozturk A. The efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey. Acta Haematol 2006;116:146-149.

  150. Suvajdzic N, Stankovic B, Artiko V, Cvejic T, Bulat V, Bakrac M, et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura. Platelets 2006;17:227-230.

  151. Satake M, Nishikawa J, Fukagawa Y, Akashi K, Okamoto T, Yoshida T, et al. The long-term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007;22:2233-2237.

  152. Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, et al. Helicobacter pylori eradication shifts monocy- te Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest 2008;118:2939-2949.

  153. Kong R, Qiu HC, Wu PF, Niu XH, Shen WX, Wang Y. [Clinical significance of Helicobacter pylori in pathogenesis of idiopathic thrombocytopenic purpura]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008;16:1222-1226.

  154. Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Esfahani FS. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: A controlled trial. Am J Hematol 2008;83:376-381.

  155. Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Keshtkar-Jahromi M, Esfahani FS. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Am J Hematol 2008;83:376- 381.

  156. Suzuki T, Matsushima M, Shirakura K, Koike J, Masui A, Takagi A, et al. Association of inflammatory cytokine gene polymor- phisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori. Di- gestion 2008;77:73-78.

  157. Scandellari R, Allemand E, Vettore S, Plebani M, Randi ML, Fabris F. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. Blood Coagul Fibrinolysis 2009;20:108-113.

  158. Tsumoto C, Tominaga K, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, et al. Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. Ann Hematol 2009;88:789- 793.

  159. Wu S, Li Y, Jian Z, Tang F. [Anti-Helicobacter pylori treatment in patients with idiopathic thrombocytopenic purpura]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:1251-1254.

  160. Tag HS, Lee HS, Jung SH, Kim BK, Kim SB, Lee A, et al. Effects of Helicobacter pylori eradication in patients with immune throm- bocytopenic purpura. Korean J Hematol 2010;45:127-132.

  161. Sato R, Murakami K, Okimoto T, Watanabe K, Kodama M, Fujioka T. Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. Journal of gastroenterology 2011;46:991-997.

  162. Payandeh M, Sohrabi N, Zare ME, Kansestani AN, Hashemian AH. Platelet count response to Helicobacter pylori eradication in iranian patients with idiopathic thrombocytopenic purpura. Mediterr J Hematol Infect Dis 2012;4:e2012056.

  163. Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Staczek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol 2017;23:1521-1540.

  164. Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003;198:1147-1156.

  165. Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter 1997;2 Suppl 1:S13-16.

  166. Toh BH, Chan J, Kyaw T, Alderuccio F. Cutting edge issues in autoimmune gastritis. Clinical reviews in allergy & immunology 2010.

  167. Hershko C, Patz J, Ronson A. The anemia of achylia gastrica revisited. Blood Cells Mol Dis 2007;39:178-183.

  168. Correa P. New strategies for the prevention of gastric cancer: Helicobacter pylori and genetic susceptibility. J Surg Oncol 2005;90:134-138; discussion 138.

  169. Lee YC, Lin JT. Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level. J Gastroenterol Hepatol 2017;32:1160-1169.

  170. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al. Helicobacter pylori eradication has the po- tential to prevent gastric cancer: A State-of-the-Art Critique. Am J Gastroenterol 2005;100:2100-2115.

  171. Fry LC, Monkemuller K, Malfertheiner P. Prevention of gastric cancer: a challenging but feasible task. Acta Gastroenterol Lati- noam 2007;37:110-117.

  172. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-386.

  173. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9 Suppl 2:59-69.




2020     |     www.medigraphic.com